Genematrix Inc. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genematrix Inc. with three other
companies in this sector in South Korea:
MG Med Inc
sales of 5.39 billion Korean Won [US$4.55 million]
Pangen Biotech Inc
(3.73 billion Korean Won [US$3.15 million]
(5.92 billion Korean Won [US$5.00 million]
Genematrix Inc. reported sales of 5.32 billion Korean Won (US$4.49 million)
December of 2015.
decrease of 20.4%
versus 2014, when the company's sales were 6.68 billion Korean Won.